Login / Signup

More than a decade since the latest CONSORT non-inferiority trials extension: do infectious diseases trials do enough?

Adam S KomorowskiCarson Ka-Lok LoAndrew K KapoorMarek SmiejaMark LoebDominik MertzAnthony D Bai
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
More than a decade after the Consolidated Standards of Reporting Trials group released a reporting items checklist for non-inferiority randomized controlled trials, the infectious diseases literature continues to underreport these items. Trialists, journals, and peer reviewers should redouble their efforts to ensure infectious diseases studies meet these minimum reporting standards.
Keyphrases
  • infectious diseases
  • adverse drug
  • randomized controlled trial
  • systematic review
  • clinical trial
  • quality improvement
  • case control
  • double blind